MFAP5 and gastric cancer: Additionally, as there are few GC patients undergoing immunotherapy currently and since our conclusions rely on transcriptomic data from public databases, validation of the relationship between cluster 6 or MFAP5 expression and immunotherapy responsiveness in an immunotherapy cohort is crucial going forward.